Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 22 March 2022
Sec. Translational Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.851663
This article is part of the Research Topic Therapeutic Advances in Melatonin Research View all 7 articles

RETRACTED: Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway

Retracted

A retraction of this article was approved in:

  1. Retraction: Melatonin mediates osteoblast proliferation through the STIM1/ORAI1 pathway

    1. Read retraction
Lili CaoLili Cao1Keda YangKeda Yang2Wei YuanWei Yuan2Siming ZhouSiming Zhou2Rui ZhaoRui Zhao3Shui Qiu Shui Qiu2*
  • 1Department of Medical Oncology, First Hospital of China Medical University, Shenyang, China
  • 2Department of Orthopedics, First Hospital of China Medical University, Shenyang, China
  • 3Minimally Invasive Orthopedic Surgery Ward, Shenyang Orthopedic Hospital, Shenyang, China
This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Cao L, Yang K, Yuan W, Zhou S, Zhao R and Qiu S (2022) Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway. Front. Pharmacol. 13:851663. doi: 10.3389/fphar.2022.851663

Received: 10 January 2022; Accepted: 08 March 2022;
Published: 22 March 2022; Retracted: 28 September 2023.

Edited by:

Alejandro Romero, Complutense University of Madrid, Spain

Reviewed by:

Dun-Xian Tan, The University of Texas Health Science Center at San Antonio, United States
Daniel P Cardinali, UCA Pontificia Universidad Católica Argentina, Argentina

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.